Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.

Additive interactions can have public health and etiological implications but are infrequently reported. We assessed departures from additivity on the absolute risk scale between 9 established breast cancer risk factors and 23 susceptibility single-nucleotide polymorphisms (SNPs) identified from gen...

Descripció completa

Dades bibliogràfiques
Autors principals:	Joshi, A, Lindström, S, Hüsing, A, Barrdahl, M, VanderWeele, T, Campa, D, Canzian, F, Gaudet, M, Figueroa, J, Baglietto, L, Berg, C, Buring, J, Chanock, S, Chirlaque, MD, Diver, W, Dossus, L, Giles, G, Haiman, C, Hankinson, SE, Henderson, B, Hoover, R, Hunter, D, Isaacs, C, Kaaks, R, Kolonel, L
Format:	Journal article
Idioma:	English
Publicat:	Oxford University Press 2014

Ítems similars

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium
per: Campa, D, et al.
Publicat: (2011)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
per: Campa, D, et al.
Publicat: (2011)

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
per: Barrdahl, M, et al.
Publicat: (2014)

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
per: Cox, D, et al.
Publicat: (2006)

Haplotypes of the estrogen receptor beta gene and breast cancer risk.
per: Cox, D, et al.
Publicat: (2008)

An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
per: Campa, D, et al.
Publicat: (2012)

A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
per: Schumacher, F, et al.
Publicat: (2007)

A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.
per: Daniele Campa, et al.
Publicat: (2014-01-01)

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
per: Patel, A, et al.
Publicat: (2008)

Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
per: Daniele Campa, et al.
Publicat: (2018-04-01)

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
per: Setiawan, V, et al.
Publicat: (2007)

Genetic polymorphisms of the <it>GNRH1 </it>and <it>GNRHR </it>genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
per: Lund Eiliv, et al.
Publicat: (2009-07-01)

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
per: Haiman, C, et al.
Publicat: (2011)

Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
per: Haiman, C, et al.
Publicat: (2007)

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
per: Tsilidis, K, et al.
Publicat: (2013)

Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.
per: Gu, F, et al.
Publicat: (2010)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
per: Shui, I, et al.
Publicat: (2014)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
per: Shui, I, et al.
Publicat: (2014)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
per: Lindström, S, et al.
Publicat: (2010)

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
per: Ahn, J, et al.
Publicat: (2009)

Estrogens and breast cancer
per: HANKINSON SUSAN E, et al.
Publicat: (1997-01-01)

The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk.
per: Annamaria Pezzotti, et al.
Publicat: (2009-01-01)

Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
per: Machiela, M, et al.
Publicat: (2012)

Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort
per: Alexandre Lafourcade, et al.
Publicat: (2018-02-01)

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
per: Koutros, S, et al.
Publicat: (2010)

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
per: Travis, R, et al.
Publicat: (2009)

Prospective analysis of circulating metabolites and breast cancer in EPIC
per: His, M, et al.
Publicat: (2019)

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
per: Siddiq, A, et al.
Publicat: (2012)

Estrogens and breast cancer Los estrógenos y el cáncer de mama
per: SUSAN E HANKINSON, et al.
Publicat: (1997-07-01)

Body mass index and breast cancer survival: a Mendelian randomization analysis
per: Guo, Q, et al.
Publicat: (2017)

Biological embodiment of educational attainment and future risk of breast cancer: findings from a French prospective cohort
per: Cyrille Delpierre, et al.
Publicat: (2025-02-01)

Response to: Letter by Litwack and DeGruttola regarding “Moral controversies and academic public health: Notes on navigating and surviving academic freedom challenges”
per: Tyler J. VanderWeele
Publicat: (2024-12-01)

Moral controversies and academic public health: Notes on navigating and surviving academic freedom challenges
per: Tyler J. VanderWeele
Publicat: (2023-12-01)

Viewpoint diversity in public health
per: Tyler J. VanderWeele
Publicat: (2023-08-01)

Translation in fragile X: no home runs in the first at-bat
per: Jeremy Veenstra-VanderWeele
Publicat: (2017-06-01)

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
per: Li, K, et al.
Publicat: (2018)

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
per: Lindström, S, et al.
Publicat: (2012)

Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies
per: Calle, E, et al.
Publicat: (1996)

Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort
per: Fortner, RT, et al.
Publicat: (2020)

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
per: Kuanrong Li, et al.
Publicat: (2018-12-01)